CK Life Sciences International Holdings Inc (hkse:00775) Share Price

Company Profile

Business description
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
Contact
2 Dai Fu Street
Tai Po Industrial Estate
Tai Po
Hong Kong
HKG
T: +852 21261212
https://www.ck-lifesciences.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,925

Recommended

Trading at an 18% discount, this wide-moat stock is a rare find.

Malik Ahmed Khan, CFA | 22 September 2026

Discounted exit raises investor concerns.

Yingqi Tan, CFA | 21 September 2026

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Jacob Robbins | 21 September 2026

Index	Last price	Change	% Change
All Ordinaries	8,845.60	51.40	-0.58%
CAC 40	8,077.80	3.63	-0.04%
DAX 40	25,408.64	142.11	0.56%
Dow JONES (US)	51,828.62	478.64	0.93%
FTSE 100	10,695.25	15.26	0.14%
HKSE	24,510.09	251.04	-1.01%
NASDAQ	27,068.72	129.34	0.48%
Nikkei 225	66,364.20	850.21	1.30%
NZX 50 Index	13,811.11	13.72	-0.10%
S&P 500	7,743.41	39.28	0.51%
S&P/ASX 200	8,665.00	37.00	-0.43%
SSE Composite Index	3,888.37	48.15	-1.22%